Inmune Bio (INMB)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

getbaraka.com

About Inmune Bio (INMB)

INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.

Open
USD8.40
High
USD10.73
Low
USD8.40
52 Week High
USD14.74
Monthly Return
-23.50%
Revenue
0M

Avg. Daily Vol.
106.77k
Market Cap.
152M
52 Week Low
6.50
Annual Return
0.70%

Stock News

4 hours ago

3 Superior German Dividend Stocks Offering Minimum 3.1% Yield

Yahoo

6 hours ago

UPDATE 1-Rio Tinto, Eramet and LG Energy seek to develop lithium extraction tech for Chile

Yahoo

6 hours ago

Exploring April 2024's Noteworthy US Dividend Stocks

Yahoo

6 hours ago

Milei Trumpets Quarterly Budget Surplus in Argentina TV Address

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App

Build Your Long Term Wealth

A modern investment app with fair pricing.

Get the App

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Explore

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Get Premium